Tag: 12a

Latest News

Synlogic Presents Data from Phase 1/2a Study of SYNB1618 at the Annual Symposium of the Society for the Study of Inborn Errors of Metabolism (SSIEM)

Newsemia
CAMBRIDGE, Mass.–(BUSINESS WIRE)–<a href="https://twitter.com/search?q=%24SYBX&src=ctag" target="_blank">$SYBX</a> <a href="https://twitter.com/hashtag/PKU?src=hash" target="_blank">#PKU</a>–Synlogic Presents Data from Phase 1/2a Study of SYNB1618 at the Annual Symposium of the Society for the...
Latest News

Resumen: RIBOMIC anuncia resultados positivos de la primera línea del ensayo clínico de fase 1/2a de RBM-007 (estudio SUSHI) en sujetos con degeneración macular húmeda relacionada con la edad

Newsemia
TOKYO–(BUSINESS WIRE)–RIBOMIC, Inc., una compañía farmacéutica en etapa clínica especializada en terapias de aptámeros y cotizada en el Mothers Market de la Bolsa de Tokio...
Latest News

Synlogic Reports Positive Interim Phase 1/2a Data Demonstrating Safety, Tolerability and Proof-of-Mechanism in Healthy Volunteers for SYNB1618, in Development for the Management of Phenylketonuria (PKU)

Newsemia
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Synlogic Reports Positive Interim Data Demonstrating Safety, Tolerability and Proof-of-Mechanism in Healthy Volunteers for SYNB1618 for PKU Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World